In this section, most widely used risk classification systems for recurrence and progression explained. As non-muscle invasive bladder cancer is recurrent and progressive disease, it is very important to risk stratify patients to guide treatment and follow-up. In seperate headlines formation and shortcomings of these classifications are highlighted.